Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1992; 68(04): 481-482
DOI: 10.1055/s-0038-1646303
DOI: 10.1055/s-0038-1646303
Letters to the Editor
Erythropoietin Doping in Athletes: Possible Detection Through Measurement of Fibrinolytic Products
Further Information
Publication History
Received 09 April 1992
Accepted after revision 25 May 1992
Publication Date:
04 July 2018 (online)
-
REFERENCES
- 1 Over J, Sixma JJ, Bruïne MH, Trieschnigg MC, Vlooswijk RA, Beeser-Visser NH, Bouma BN. Survival of 125-iodine labeled Factor VIII in normals and patients with classic hemophilia. Observation on the heterogeneity of human Factor VIII. J Clin Invest 1978; 62: 223-234
- 2 Nankivell BJ, Koutts J, Harris DCH. Human recombinant erythropoietin (rHuEpo) stimulates platelet production and thrombosis. Kidney Int 1990; 38: 559 (abstract)
- 3 Akizawa T, Kinugasa E, Kitaoka T, Koshikawa S. Effects of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients. Nephron 1991; 58: 400-406
- 4 Davis RB, Boyd DG, McKinney ME, Jones CC. Effects of exercise and exercise conditioning on blood platelet function. Med Sci Sport Exerc 1990; 22: 49-53
- 5 Abels R. Review of hematologic effects of erythropoietin. Semin Nephrol 1990; 10: 01-10
- 6 Jelkmann W. Renal erythropoietin: properties and production. Rev Physiol Biochem Pharmacol 1986; 104: 140-179
- 7 Szewczuk J, Mazerska M, Malyszko J, Kalinowski M, Mysliwiec M. Increase in fibrinolytic activity after erythropoietin therapy. Thromb Haemostas 1992; 67: 284